Meloxicam emulgel potently suppressed cartilage degradation in knee osteoarthritis: Optimization, formulation, industrial scalability and pharmacodynamic analysis
CONCLUSION: MLX-emulgel may be a potential candidate for translating in to a clinically viable dosage form in the management of knee OA.PMID:37348266 | DOI:10.1016/j.colsurfb.2023.113399
Source: Colloids and Surfaces - Category: Biotechnology Authors: Vaskuri Gs Sainaga Jyothi Harithasree Veerabomma Rahul Kumar Dharmendra Kumar Khatri Shashi Bala Singh Jitender Madan Source Type: research
More News: Biotechnology | Meloxicam | Mobic | Nanotechnology | Osteoarthritis | Pain | Pain Management | Skin | Study